Pulmonology Advisor8h
No Link Seen Between Preop GLP-1 Receptor Agonist Use and Postop Aspiration Pneumonia
HealthDay News — Preoperative glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is not associated with short-term postoperative aspiration pneumonia, according to a study published online March ...
Pulmonology Advisor8h
AAOS: Stopping GLP-1 RAs 14 Days Before Surgery Can Minimize Complications
Continuing GLP-1 RA use through surgery increases risk for surgical complications including aspiration and conversion to intubation ...
Medscape11h
GLP-1 RAs Unlikely to Increase Suicide Risk
Patients with diabetes or obesity receiving GLP-1 RAs are unlikely to experience an increase in the already low rates of ...
AHA/ASA Journals12h
XBP1s-EDEM2 Prevents the Onset and Development of HFpEF by Ameliorating Cardiac Lipotoxicity
BACKGROUND: Morbidity and mortality of heart failure with preserved ejection fraction (HFpEF) is increased in metabolic disorders. However, options for preventing and treating these prevalent outcomes ...
Helix Launches 23,000-Patient Clinico-Genomic Cohort for Autoimmune Diseases to Advance Drug Discovery and Development
Helix, a leader in population genomics and precision health, is announcing a new comprehensive clinico-genomic virtual registry of autoimmune disease patients. Consisting of over 23,000 individuals ...
Medical Dialogues8d
GLP-1 RA Use Linked to Lower Hematologic Cancer Risk in T2D Patients: JAMA
According to a study published in JAMA Network Open, among patients with type 2 diabetes (T2D), the use of glucagon-like ...
Becker's Hospital Review14d
GLP-1s reshape key service lines: What to know
Blockbuster GLP-1 medications like Ozempic and Wegovy are transforming patient care, altering surgery volumes and redefining the healthcare industry's financial landscape. Beyond weight loss ...
Monthly Prescribing Reference14d
Risk for Specific Hematologic Cancers Down With GLP-1 Receptor Agonist Use in T2DM
HealthDay News — For patients with type 2 diabetes (T2D), glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is associated with a reduced risk for developing hematologic cancers compared ...
The Cardiology Advisor14d
GLP-1 Receptor Agonists May Have Broader Range of Benefits, Risks
With respect to risks, GLP-1RA use was significantly associated with an increased risk of gastrointestinal disorders, hypotension, syncope, arthritic disorders, drug-induced pancreatitis, and other ...
Frontiers14d
The immunomodulatory effects of GLP-1 receptor agonists in neurogenerative diseases and ischemic stroke treatment
1 The neuroprotection of glucagon like peptide-1 receptor agonists in neurodegenerative and cerebrovascular disorders Figure 2. The principal mechanisms of GLP-1RAs in the regulation of neurological ...
Medical Xpress14d
Stopping GLP-1 RAs 14 days before surgery can minimize complications
Stopping glucagon-like peptide-1 receptor agonist (GLP-1 RA) treatment 14 days before total joint arthroplasty can minimize risks for complications, according to a study presented at the annual ...
ophthalmologyadvisor14d
GLP-1 Drugs Associated With a Reduced Risk of Multiple Age-Related Ocular Diseases
Among 9669 patients included in the analysis, 84.4% had diabetes and an average BMI of 36.2. The average age of GLP-1 RA users was 61.1 years, making them younger than patients taking metformin, ...